J. Patrick Condreay - Concepedia

Author

J. Patrick Condreay

Also Known As

J P Condreay, J Patrick Condreay, J. Condreay, J. P. Condreay, J. Patrick Condreay, J.Patrick Condreay, James Patrick Condreay

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)The University of Texas at Austin Target (United States)

About

J. Patrick Condreay is an author at Research Triangle Park Foundation specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1K
2	Engineering	3	3	248
3	Natural Sciences	3	3	82
4	Public Health	2	2	189
5	Health Sciences	1	1	65

J. Patrick Condreay

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector J. Patrick Condreay, Sam M. Witherspoon, William C. Clay, Proceedings of the National Academy of Sciences Molecular VirologyRecombinant BaculovirusesMammalian CellsImmunotherapyMedicine	1999	421
Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic Antony Schwartz, Matthew A. Stiegel, Nicole Mh Greeson, Applied Biosafety EngineeringDecontaminationAir Pollution FiltrationOccupational Health SciencesN95 Respirators	2020	177
Chromosomal Integration of Transduced Recombinant Baculovirus DNA in Mammalian Cells Raymond V. Merrihew, William C. Clay, J. Patrick Condreay, Journal of Virology Viral ReplicationMolecular VirologyChromosomal IntegrationMammalian CellsMedicine	2001	96
Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells Alexandra Spenger, Wolfgang Ernst, J. Patrick Condreay, Protein Expression and Purification Molecular VirologyA TreatmentMedicinePathogenesisViral Pathogenesis	2004	68
Direct labelling of the human P2X<sub>7</sub>receptor and identification of positive and negative cooperativity of binding A.D. Michel, Laura J. Chambers, William C. Clay, British Journal of Pharmacology	2007	67
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Peter Watkins, J. Patrick Condreay, Brian E. Huber, PubMed Metallothionein PromoterCancer ResearchRadiation OncologyImpaired ProliferationVector Control Plasmid	1996	65
Identification of regions of the P2X<sub>7</sub>receptor that contribute to human and rat species differences in antagonist effects A.D. Michel, William C. Clay, Sin‐Wei Ng, British Journal of Pharmacology	2008	64
Production of monoclonal antibodies using recombinant baculovirus displaying gp64–fusion proteins Kathryn M. Lindley, Jui‐Lan Su, Paula K. Hodges, Journal of Immunological Methods Molecular VirologyNeurovirologyImmunologyVirologyAntibody Engineering	2000	63
BacMam technology and its application to drug discovery Robert S. Ames, Thomas A. Kost, J. Patrick Condreay Expert Opinion on Drug Discovery EngineeringSynthetic VirologyImmunologyGene DeliverySynthetic Immunology	2007	43
Mutants of bacteriophage T7 that escape F restriction Ian J. Molineux, Clare K. Schmitt, J. Patrick Condreay Journal of Molecular Biology MedicineBacteriophageEscape F RestrictionMicrobiologyPhage Biology	1989	39

Page 1